CD226 and systemic sclerosis: In systemic sclerosis patients’ skin tissue, CD226 overexpression exacerbates fibrotic progression by enhancing T cell infiltration and prompting the secretion of pro-inflammatory cytokines including TNF-α and IL-6 [90].